# Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension

> **NCT00280540** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 648 (—)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Valsartan/Hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00280540
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2006-08
- **Final completion:** —
- **Target enrollment:** 648 (—)
- **Last updated:** 2010-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00280540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00280540, "Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00280540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*